These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 10703925

  • 1. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A, Verlinden L, van Etten E, Shi L, Wu Y, D'Halleweyn C, Van Haver D, Zhu GD, Chen YJ, Zhou X, Haussler MR, De Clercq P, Vandewalle M, Van Baelen H, Mathieu C, Bouillon R.
    J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
    [Abstract] [Full Text] [Related]

  • 2. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM, Schwartz Z, Posner GH, Sylvia VL, Dean DD, Boyan BD.
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [Abstract] [Full Text] [Related]

  • 3. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A, Verlinden L, Van Baelen H, Sabbe K, D'Hallewyn C, De Clercq P, Vandewalle M, Bouillon R.
    J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
    [Abstract] [Full Text] [Related]

  • 4. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
    Boyan BD, Posner GH, Greising DM, White MC, Sylvia VL, Dean DD, Schwartz Z.
    J Cell Biochem; 1997 Sep 15; 66(4):457-70. PubMed ID: 9282324
    [Abstract] [Full Text] [Related]

  • 5. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS, Robinson M, Wang G, Palmore GT, Gennaro L, Vouros P, De Clercq P, Vandewalle M, Young W, Ling S, Verstuyf A, Bouillon R.
    Arch Biochem Biophys; 2007 Apr 15; 460(2):254-61. PubMed ID: 17196157
    [Abstract] [Full Text] [Related]

  • 6. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C.
    J Cell Biochem; 2003 Feb 01; 88(2):274-81. PubMed ID: 12520526
    [Abstract] [Full Text] [Related]

  • 7. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H, Spinner D, Reddy GS, Lindley IJ.
    J Cell Biochem; 2000 Apr 01; 78(1):112-20. PubMed ID: 10797570
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20.
    Zhou X, Zhu GD, Van Haver D, Vandewalle M, De Clercq PJ, Verstuyf A, Bouillon R.
    J Med Chem; 1999 Sep 09; 42(18):3539-56. PubMed ID: 10479287
    [Abstract] [Full Text] [Related]

  • 9. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
    Sicinski RR, Prahl JM, Smith CM, DeLuca HF.
    J Med Chem; 1998 Nov 05; 41(23):4662-74. PubMed ID: 9804706
    [Abstract] [Full Text] [Related]

  • 10. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.
    J Bone Miner Res; 2001 Apr 05; 16(4):625-38. PubMed ID: 11315990
    [Abstract] [Full Text] [Related]

  • 11. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC, Mouriño A, Rochel N, Moras D.
    J Med Chem; 2006 Mar 09; 49(5):1509-16. PubMed ID: 16509569
    [Abstract] [Full Text] [Related]

  • 12. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G, Verlinden L, Rochel N, Claessens F, De Clercq P, Vandewalle M, Tocchini-Valentini G, Moras D, Bouillon R, Verstuyf A.
    Mol Pharmacol; 2005 May 09; 67(5):1566-73. PubMed ID: 15728261
    [Abstract] [Full Text] [Related]

  • 13. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
    Pérez-García X, Rumbo A, Larriba MJ, Ordóñez P, Muñoz A, Mouriño A.
    Org Lett; 2003 Oct 30; 5(22):4033-6. PubMed ID: 14572242
    [Abstract] [Full Text] [Related]

  • 14. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 30; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 15. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep 30; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 16. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 17. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M, Uskokovic M, Hisatake J, Hisatake Y, Koike K, Komiyama A, Koeffler HP.
    Cancer Res; 2001 Apr 15; 61(8):3361-8. PubMed ID: 11309293
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA, Rossi AM, Picotto G, Benassati S, Boland RL.
    J Cell Biochem; 2004 Oct 01; 93(2):384-97. PubMed ID: 15368364
    [Abstract] [Full Text] [Related]

  • 19. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
    Nakagawa K, Kurobe M, Ozono K, Konno K, Fujishima T, Takayama H, Okano T.
    Biochem Pharmacol; 2000 Mar 15; 59(6):691-702. PubMed ID: 10677586
    [Abstract] [Full Text] [Related]

  • 20. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M, Clarin A, Binderup E, Björkling F, Hansen CM, Carlberg C.
    J Cell Biochem; 1998 Dec 01; 71(3):340-50. PubMed ID: 9831071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.